NCT07101159 2025-08-03
Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients
Fujian Cancer Hospital
Phase 2 Not yet recruiting
Clinical Trials
9 trialsNCT03423199 2024-03-22
PATHWAY
National Cancer Center, Japan
Phase 3 Active not recruiting
NCT04389424 2020-05-15
NUTRIBREAST
Instituto Jalisciense de Cancerologia
Unknown
NCT03024580 2019-08-15
MEGA
Instituto Nacional de Cancer, Brazil
Phase 2 Unknown
NCT02995772 2019-06-19
Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients
Dharmais National Cancer Center Hospital
Phase 3 Completed
NCT02488603 2015-07-02
Decision Aids for Tamoxifen Treatment in Breast Cancer Patients
National Cancer Center, Korea
Phase NA Unknown
NCT00896155 2011-08-30
CONSET
Tata Memorial Hospital
Phase 3 Unknown
NCT01157026 2010-07-05
BC
Malaysia Palm Oil Board
Phase NA Completed
NCT00532454 2010-02-10
Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen
National Cancer Center, Korea
Phase 2 Terminated